Clinical Trial Update: A Study of TAC-101 in Combination With TACE Versus TACE Alone in Asian Patients With Advanced Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating TAC-101 in combination with transarterial chemoembolization (TACE) versus TACE alone in Asian patients with hepatocellular carcinoma …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• TAC-101

Snippet

Sponsor: Taiho Oncology, Inc. | Conditions: Advanced Hepatocellular Carcinoma | Phase 2 | Status: WITHDRAWN